Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)
Clinical trial NCT01545076 · COMPLETED
Trial details
- NCT number
- NCT01545076
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2016-09-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.